Beth Boyer
@bethboyer-mph.bsky.social
Global Health | Access to Medicines| Health Policy| Health Equity|
Researcher @ Duke-Margolis | Cats | Running | Taylor Swift |
Researcher @ Duke-Margolis | Cats | Running | Taylor Swift |
The ALIGN Consortium -- a multi-country initiative that aims to improve health outcomes by strengthening critical decision-making systems for country-level innovation introduction -- has launched a Substack! Check it out and follow along with what we are learning! open.substack.com/pub/aligncon...
December 8, 2025 at 8:27 PM
The ALIGN Consortium -- a multi-country initiative that aims to improve health outcomes by strengthening critical decision-making systems for country-level innovation introduction -- has launched a Substack! Check it out and follow along with what we are learning! open.substack.com/pub/aligncon...
Generic #drugrepurposing offers a promising tool for drug development - but a system built for pharma will never realize this potential. In our new guest commentary, we argue #FDA can take actions to fix this. www.biocentury.com/article/657654
FDA should take a more active role in updating drug labels — when there’s strong evidence
Every year, promising new uses for generic drugs emerge from academia, non-profits, and patient groups — yet most never reach patients. Not because ...
www.biocentury.com
November 21, 2025 at 2:59 PM
Generic #drugrepurposing offers a promising tool for drug development - but a system built for pharma will never realize this potential. In our new guest commentary, we argue #FDA can take actions to fix this. www.biocentury.com/article/657654
📣JUST PUBLISHED: Our white paper on regulatory opportunities to advance generic drug repurposing is now available online! This paper explores the role of the regulator and policy actions it can take to support repurposing initiatives. @dukemargolis.bsky.social
healthpolicy.duke.edu/publications...
healthpolicy.duke.edu/publications...
Regulatory Opportunities to Advance Generic Drug Repurposing
healthpolicy.duke.edu
September 5, 2025 at 2:26 PM
📣JUST PUBLISHED: Our white paper on regulatory opportunities to advance generic drug repurposing is now available online! This paper explores the role of the regulator and policy actions it can take to support repurposing initiatives. @dukemargolis.bsky.social
healthpolicy.duke.edu/publications...
healthpolicy.duke.edu/publications...
Why can't I get over this feeling that I'm cheating when I use ChatGPT to help me write something? I know most people use it, but I have this stubbornness that tells me I'm a capable writer and shouldn't be taking short cuts. How do I get past this!? 😩
June 9, 2025 at 5:18 PM
Why can't I get over this feeling that I'm cheating when I use ChatGPT to help me write something? I know most people use it, but I have this stubbornness that tells me I'm a capable writer and shouldn't be taking short cuts. How do I get past this!? 😩
Reposted by Beth Boyer
Measles and tariffs, what century is this?
April 3, 2025 at 12:47 PM
Measles and tariffs, what century is this?
Reposted by Beth Boyer
It turns out it’s always veep and never house of cards
March 26, 2025 at 12:58 AM
It turns out it’s always veep and never house of cards
Reposted by Beth Boyer
A brief timeline of the Signal group chat story so far
March 26, 2025 at 7:07 PM
A brief timeline of the Signal group chat story so far
Reposted by Beth Boyer
USAID under threat: www.nytimes.com/live/2025/02...
Trump Administration Live Updates: USAID Could Be Shut Down, Musk Says
www.nytimes.com
February 3, 2025 at 2:31 PM
USAID under threat: www.nytimes.com/live/2025/02...
NIH issues a policy to widen access to medical products that emerge from government-funded research www.statnews.com/pharmalot/20... via @statnews.com
NIH issues a policy to widen access to medical products that emerge from government-funded research
NIH policy asks companies seeking licenses to sell medical products invented with government research to submit plans for ensuring greater access to patients.
www.statnews.com
January 15, 2025 at 1:49 PM
NIH issues a policy to widen access to medical products that emerge from government-funded research www.statnews.com/pharmalot/20... via @statnews.com
"The removal is a major win for the PBMs and the health insurers that own them."
And yet, leaders are confused about why Americans are embracing vigilantism...
www.statnews.com/2024/12/19/r...
And yet, leaders are confused about why Americans are embracing vigilantism...
www.statnews.com/2024/12/19/r...
House Republicans abandon PBM reform in push to keep government open
Lawmakers are aiming to pass a government funding bill with extensions for public health programs and telehealth flexibilities.
www.statnews.com
December 20, 2024 at 2:41 PM
"The removal is a major win for the PBMs and the health insurers that own them."
And yet, leaders are confused about why Americans are embracing vigilantism...
www.statnews.com/2024/12/19/r...
And yet, leaders are confused about why Americans are embracing vigilantism...
www.statnews.com/2024/12/19/r...
📣New Publication!📣
Check out our proposed solution to help unlock the full potential of generic drugs to meet patient needs. @dukemargolis.bsky.social www.healthaffairs.org/content/fore...
Check out our proposed solution to help unlock the full potential of generic drugs to meet patient needs. @dukemargolis.bsky.social www.healthaffairs.org/content/fore...
Unlocking The Full Potential Of Generic Drugs For Patients | Health Affairs Forefront
Generic drug repurposing is an underused but promising tool for finding new, affordable therapies. Creating a pull incentive can spur developers to finally explore the untapped potential in these drug...
www.healthaffairs.org
November 26, 2024 at 5:03 PM
📣New Publication!📣
Check out our proposed solution to help unlock the full potential of generic drugs to meet patient needs. @dukemargolis.bsky.social www.healthaffairs.org/content/fore...
Check out our proposed solution to help unlock the full potential of generic drugs to meet patient needs. @dukemargolis.bsky.social www.healthaffairs.org/content/fore...